Table 2

Common end points after BM and PBSC collection

VariableTotal donors (N = 453)BM donors (n = 313)PBSC donors (n = 140)PHR (95% CI)
Pain (not related to G-CSF) 
    No 237 (52.3%) 118 (37.7%) 119 (85.0%) < .0001  
    Yes (no analgesics) 50 (11.0%) 38 (12.1%) 12 (8.6%)   
    Yes (nonnarcotic analgesics) 166 (36.7%) 157 (50.2%) 9 (6.4%)   
Blood allotransfusion 
    No 368 (81.2%) 229 (73.2%) 131 (93.6%) < .0001 5.3 (2.5-11.8) 
    Yes 85 (18.8%) 84 (26.8%) 9 (6.4%)   
No. of days spent in hospital after collection 
    0 118 (26.1%) 12 (3.8%) 106 (75.7%) < .0001  
    1 265 (58.5%) 240 (76.7%) 25 (17.9%)   
    2 or more 70 (15.4%) 61 (19.5%) 9 (6.4%)   
Iron supplementation 
    No 156 (34.4%) 70 (22.4%) 86 (61.4%) < .0001 6.9 (4.3-11.3) 
    Yes 273 (60.3%) 232 (74.1%) 41 (29.3%)   
    No data 24 (5.3%) 11 (3.5%) 13 (9.3%)   
VariableTotal donors (N = 453)BM donors (n = 313)PBSC donors (n = 140)PHR (95% CI)
Pain (not related to G-CSF) 
    No 237 (52.3%) 118 (37.7%) 119 (85.0%) < .0001  
    Yes (no analgesics) 50 (11.0%) 38 (12.1%) 12 (8.6%)   
    Yes (nonnarcotic analgesics) 166 (36.7%) 157 (50.2%) 9 (6.4%)   
Blood allotransfusion 
    No 368 (81.2%) 229 (73.2%) 131 (93.6%) < .0001 5.3 (2.5-11.8) 
    Yes 85 (18.8%) 84 (26.8%) 9 (6.4%)   
No. of days spent in hospital after collection 
    0 118 (26.1%) 12 (3.8%) 106 (75.7%) < .0001  
    1 265 (58.5%) 240 (76.7%) 25 (17.9%)   
    2 or more 70 (15.4%) 61 (19.5%) 9 (6.4%)   
Iron supplementation 
    No 156 (34.4%) 70 (22.4%) 86 (61.4%) < .0001 6.9 (4.3-11.3) 
    Yes 273 (60.3%) 232 (74.1%) 41 (29.3%)   
    No data 24 (5.3%) 11 (3.5%) 13 (9.3%)   

or Create an Account

Close Modal
Close Modal